Figure 1
From: Imatinib plasma levels: correlation with clinical benefit in GIST patients
Box plots and individual values of extrapolated free trough concentrations (free Cmin) in exon 9 mutated or wt KIT patients, contrasting responders’ samples (complete response, partial response, or stable disease; n=14; median=25.7 ng ml−1) vs non-responders’ (progressive disease; n=19; median=10.1 ng ml−1).
